E
Power Law company profile
EyeBio
Biotech & Life Sciences · London, United Kingdom · Founded 2021 Unicorn
Global footprint
Where EyeBio has talent and traffic
Web traffic by country
760
monthly visits
across markets
across markets
🇺🇸 United States105.3%
Patent intelligence
$1.7B patent portfolio · 1,993 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$1.7B
57.8% of valuation · 12.2× the top peer Autolus ($142M)
1,993 active patent families
Where EyeBio innovates
Molecular biologyDiseasePharmaceutical drugPharmaceutical medicinePharmacology
Above peer median on Strategic
Quality vs same-sector peers
EyeBio on the five Patsnap quality dimensions
EyeBio in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where EyeBio concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across EyeBio and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee EyeBio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.